Supplements News and Research

RSS

FDA finds inconsistent amounts of belladonna in certain homeopathic teething tablets

The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label.

23 Aug 2019

Addiction clinics market pricey, unproven treatments to desperate patients

Jason was hallucinating. He was withdrawing from drugs at an addiction treatment center near Indianapolis, and he had hardly slept for several days.

23 Aug 2019

Single course of antibiotics may boost colon cancer risk

In an extensive "data mining" analysis of British medical records, researchers at the Johns Hopkins Kimmel Cancer Center conclude that taking even a single course of antibiotics might boost--albeit slightly--the risk of developing colon cancer--but not rectal cancer--a decade later.

22 Aug 2019

Fish oils have little or no effect on risk of Type 2 diabetes

Omega-3 fats have little or no effect on risk of Type 2 diabetes according to new research from the University of East Anglia.

22 Aug 2019

Scientists discover how brown fat may help protect against obesity and diabetes

Rutgers and other scientists have discovered how brown fat, also known as brown adipose tissue, may help protect against obesity and diabetes.

21 Aug 2019

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

The U.S. Food and Drug Administration today approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.

19 Aug 2019

Liver dysfunction provokes cerebral molecular disturbances in two weeks

The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.

19 Aug 2019

FDA approves first spinal tether device to treat children with idiopathic scoliosis

The U.S. Food and Drug Administration today approved the first spinal tether device intended to be used in children and adolescents to correct the most common form of scoliosis, called idiopathic scoliosis, that has not responded to conservative treatment options, such as external bracing.

18 Aug 2019

FDA approves new drug to treat patients with myelofibrosis

Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.

18 Aug 2019

FDA approves novel device to treat symptoms associated with advanced heart failure

The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.

18 Aug 2019

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.

14 Aug 2019

Doctors should not rely on 'one-size-fits-all' guidelines when recommending vitamin D supplements

When recommending vitamin D supplements, doctors should look at each individual patient as having different requirements and not rely on "one-size-fits-all" guidelines, according to a study by researchers at Rutgers and the University of California, San Francisco.

14 Aug 2019

Age-related hearing loss could be prevented with development of novel drug

The first ever medication to treat age-related hearing loss could potentially receive FDA approval through a comprehensive study being conducted at the University of South Florida.

12 Aug 2019

Statement related to data inaccuracies with newly approved gene therapy

As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.

7 Aug 2019

AI used to find unsafe foods using consumer product reviews

A new program can track all recalled foods based from Amazon customer reviews. Called BERT, the AI program identified thousands of recalled products with an accuracy rate of 74 percent.

6 Aug 2019

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.

3 Aug 2019

Company expands development plans for drugs which slow progression to dialysis

Kibow Biotech announces that the focus on supporting and maintaining healthy kidney function with probiotics/prebiotics to potentially delay the progression to dialysis is based on its enteric toxin reduction platform technology termed "Enteric Dialysis®"

From Kibow Biotech Inc. 2 Aug 2019

Skin cancer risk falls with higher dietary vitamin A intake

A new study from Brown University shows that the dietary intake of vitamin A from plant sources is associated with a lower risk of a common type of skin cancer called squamous cell carcinoma. This is the second most common carcinoma of the skin in fair-skinned people.

1 Aug 2019

High levels of vitamin A linked to reduced skin cancer risk

People whose diets included high levels of vitamin A had a 17 percent reduction in risk for getting the second-most-common type of skin cancer, as compared to those who ate modest amounts of foods and supplements rich in vitamin A.

31 Jul 2019

FDA clears existing tests with new indications to aid in the diagnosis of Lyme disease

Today, the U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease.

30 Jul 2019